Journal articleSci Signal2019
Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer.
- Journal
- Sci Signal
- Published
- 16 July 2019
- Citations
- 64
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 5
- Biological Activity of Ras Oncogenes R01CA042978↗
- Mechanisms of PAK1 activation, signaling and tumor resistance R01CA175747↗
- ERK inhibitor resistance and ERK isoform-dependent growth in pancreatic cancer R21CA179193↗
- Targeting undruggable RAS for cancer treatment R35CA232113↗
- Identification of synthetic lethal interactors in pancreatic cancer U01CA199235↗